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Abstract 
Secretory immunoglobulin A (sIgA) is  the dominant immW1oglobulin in human milk, and apart from the ob-
vious contribution it makes towards the protection of the infant, sIgA may also form an important part of the 
defense of the mammary gland. This report involves a mother (M8)  who participated in a research study in-
vestigating the relationships between symptoms and changes in the physiology of the lactating breast during 
mastitis. Breastmilk samples were collected on Days 14, 30, 60, and 90 postpartum, to establish the normal ref-
erence range of biochemical markers, and during periods of breast inflammation. M8 experienced seven episodes 
of blocked duct(s) during the first 19 weeks, five of which occurred within the 90-day reference sample collec-
tion period. On analysis, it was found there was no detectable sIgA present in her milk samples. Medical re-
ferral and further testing resulted in a diagnosis of selective IgA deficiency, of which the mother had not been 
previously aware. M8 showed little variation in her milk composition even when suffering with blocked duct(s), 
although there was an increase in the concentration of lactoferrin in both breasts at reference collection days 
14-90. Lactoferrin concentration was also W1usually high at Day 14 (15 giL) in the left breast and continued to 
be increased in this breast until Day 60. The absence of slgA in this mother's breastmilk may have been a con-
tributing factor in her experiencing recurrent blocked ducts. 
Introduction 
S
ECRIITORY  IMMUNOGLOBULIN ([g) A (s[gA) is the dominant 
[g  in  human milk with  a concentration  in colostrum of 
approximately 10 giL, which decreases rapidly to 1- 2 giL 
by the end of the first week after birth.] It is a polymeric mo[-
ecule composed of two (or more) 'gA monomers, a J chain, 
and a secretory component. The important contribution that 
slgA  makes towards the protection of the  neonate is  well 
known!; however, it also forms an important part of the de-
fense  against pathogens that colonize and invade all  body 
surfaces that <He  bathed in  secretions. It  functions by neu-
tralizing bacterial enzymes and toxins and inhibiting bacte-
rial adhesion through the prevention of both nonspecific and 
stereochemical interactions. It is also thought to  act syner-
gistically with innate immune factors present in  secretions 
such as lactoferrin, lactoperoxidase, and mucins.3 Although 
there is a paucity of literature specifically regarding the role 
of slgA in defense of the mammary gland, there is an abun-
dance of research  regarding its effects on the limitation of 
bacterial  adherence  in  buccal,  intestinal,  urinary,  genital, 
nasal, and bronchial epithelia.3 
The  importance of the  [gA  system  in  protection of the 
mammary gland is implicated in research involving the stim-
ulation of local immunity in  a  variety of animals  with dif-
fering 'gA milk levels. The production of local antibodies in 
the mammary glands of animals infused with antigens was 
much greater and persisted longer in animals that previously 
had higher levels of milk IgA.4 in women, slgA,  in conjunc-
tion  with  lactoferrin and complement 3,  was significantly 
lower in  the milk of Gambian women who later developed 
mastitis.s These findings were maintained even when anal-
ysis was adjusted for stage of lactation, season, ;md parity. 
IgA deficiency is defined as either primary or secondary 
in etiology. Secondary deficiency may be  related to a range 
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of factors,  such  as drugs and  infections (e.g.,  rubella,  cy-
tomegloviruses,  Epstein-Barr  virus).  Although  [gA  defi-
ciency is generally considered permanent, occasionally there 
is spontaneous remission, for instance, when the causal med-
ication  is  ceased.6  Several  physiological variables, such as 
psychological stress, intense endurance exercise, and sleep 
deprivation, have been a&sociated with decreased concen-
trations of slgA in saliva, where the concentration of salivary 
slgA was inversely related to the level of psychological stress 
experienced?,R As an increased level of stress has been found 
to be  a risk factor for mastitis in multiparous women who 
are breastfeeding.9  it is possible there may be a  relationship 
among  increased  level$ of $tress,  lower  level$  of slgA  in 
brea$tmilk, and $usceptibility to ma$titi$.  However, thi$  is 
not supported by a study that found slgA in breast milk was 
positively correlated to stress in mothers, where stress was 
assessed using Cohen's Perceived Stress Scale.tO 
Selective IgA deficiency is the most common form of pri-
mary  immunodeficiency,  with  a  reported  frequency  of 
1:500  in  the  Caucasiiln  populiltion.ll  Filctors  ilssociilted 
with the prevalence of selective 'gA deficiency include a 
family history and the country of origin. [n  particular, se-
lective [gA deficiency varies significantly across differing 
ethnic groups where, among  healthy blood  donor$,  the 
prevalence  has  been  reported  as  ranging  from  one  in 
328-633 for those of European ancestry to one in 5,000 in 
China and one in  18,500 in Japan.12  Caution in  the inter-
pretation of some of these findings has been recommended 
because of the variation in definitions used in some diag-
nostic testing.  I !  Most laboratories now define the adult ref-
erence range as 0.8-4.0 giL, where deficiency in IgA is de-
fined  as  < 0.07  g/L,  which  is  the  concentration  below 
which  nephelometry (the  routine commercial  laboratory 
test used for [gs) becomes unreliable.!3 
Case Report 
This report involves a mother (M8), a Caucasian, 33-year-
old primipara, who participated in  a research study investi-
gating  the  relationships  between  clinical  descriptors  and 
changes in the physiology of the lactating breast during mas-
titis.14-16 'n brief, the study required samples of milk  from 
both breasts and 24-hour urine samples to  be collected on 
Days 5,  14,  30, 60,  and 90 postpartum and blood  to be col-
lected on Days 5 and  14,  to establish the normal reference 
range of biochemical markers for each individual participant 
in the cohort.  Breastmilk samples were hand-expressed, and 
a  single blood sample was taken at a  point during the 24-
hour urine colk>etion  that was convenient for  the mother. 
Milk samples were analyzed for sodium (Na), chloride (CI), 
lactose, glucose, C-reactive protein (CRP),  slgA, lactoferrin, 
and serum albumin. Urine samples were analyzed for lac-
tose, and blood samples were assayed for lactose and CRP. 
When women reported inflammatory breast symptoms the 
researcher visited them in their home daily and again at fol-
low-up, 7 days after resolution of symptoms. During these 
visits  samples of blood,  milk  from  the affected  and  con-
tralateral  breasts, and  24-hour  urine  specimens were col-
lected. Mothers were interviewed at reference and mastitis 
time points to establish the presence of any co-existing ill-
ness and breast pathology. Hypothesis testing of all outcome 
measures was based on analyses of variance with repeilted 
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measures. All  analyses were adjusted for  stage of lactation 
and co-existing breast and systemic pathologies. 
Inflammation of the breast during lactation is experienced 
in differing degrees of severity, and not all episodes of breast 
inflammation  are classified  as  mastitis.  Clinically,  milder 
cases of focal inflilmmation that arc not accompanied by sys-
temic illness arc traditionally diagnosed as blocked duct(s).  17 
Often  these episodes arc manifested by a  localized  area of 
erythema  and  tenderness that may be accompanied  by  a 
nodular lumpiness on palpation and usually  respond to the 
conservative management of increased frequency of breast-
feeding and massage of the affected  area.17 
Blocked duct(s), for the purpose of this study, were de-
fined as localized inflammatory breast symptoms that were 
present for  less  than 24  hours with no accompanying sys-
temic symptoms. Localized  inflammatory breast symptoms 
were defined as either focal  erythema or tenderness/pain 
that mayor may not be associated with a nodular lumpiness 
on palpation. During the study period there were 13 episodes 
of blocked ducts experienced by eight mothers. Eleven of the 
episodes  were  accompanied  by  co-existing  pathologies. 
Three  mothers  experiencing  only  one  episode  each  of 
blocked duct(s) also suffered with either nipp!e trauma (/1  = 
2) or perceived oversupply (/I  =  1).  Two mothers had diag-
nosed medical disorders:  Hashimoto's thyroiditis  and 'gA 
deficiency. The mother with Hashimoto's thyroiditis (M21) 
experienced four episodes of mastitis late in her lactation (be-
hveen  Day 280 and  Day 400)  and one episode of blocked 
duct(s)  (Day 310)  during a  period  of significant  personal 
stress. The mean concentration of slgA in her breastmilk dur-
ing  the  9O-day  reference  sample collection  period  (0.91  + 
0.15  g/L) was  already  significantly  lower  (t22  =  4.9,  P < 
0.001) than that of the other asymptomatic mothers in  the 
study cohort (1.1  +  0.5 giL). The mother (MS)  with IgA  de-
ficiency is the subject of this case report, and she experienced 
seven of the 13 observed episodes of blocked duct(s) within 
the first 19 weeks postpartum. 
Results 
Despite  five  of the seven  recurrent episodes of blocked 
duct(s)  occurring during the  9O-day  reference sample col-
lection period, M8 was asymptomatic at each of the routine 
reference  collection  days.  On  analysis,  there  was  no  de-
tectable slgA (detection limit, > 0.09 g/L) present in any of 
her milk samples. As a result, her Day 14 blood sample was 
sent to an  independent commercial  laboratory where IgA, 
IgG, and IgM in blood were analyzed. Normal ranges at this 
laboratory were stated as  follows:  IgA, 0.69-3.1  giL; IgG, 
6.1- 13  g/L; and  IgM,  0.53-3.32  giLlS The  results for  MS 
were <0.0667, 11.3, and 2.92 g/L, respectively, and she was 
subsequently referred for medical assessment where a diag-
nosis of selective 19A deficiency was made. M8 had not been 
previously investigated or diagnosed with  'gA deficiency, 
although she  reported multiple and  recurrent episodes of 
sinorespiratory and ear infections as a child, for which sur-
gical interventions were required. 
Unfortunately M8 was not recruited into the study until 
Day 7 postpartum, so there are no Day 5 reference sample 
results available. Components in  the remaining four  refer-
ence sample collections at Days 14-90 postpartum remained 
within the normal range for the study cohort,14 with the ex-IgA DEFICIENCY AND  RECURRENT BLOCKED  DUCT(S) 
n>plion of lactaferrin. The concentration of laclaferrin was 
very high (15 giL) in her left  breast al Day 14  compared to 
those mothers with  asymptomatic  breasts (3.8  +  2.9 giL), 
ilnd it remained slightly above the asymptomiltic mean for 
the  remaining reference sample collections at  Days 30,  60, 
and 90 postpartum (Fig. 1). The increased concentration of 
lactoferrin in milk on Day 14 was associated with an elevated 
serum eRr of 102 mg/L (where the normal eRr  in blood is 
< 10 mg/L). There was no evidence of either systemic infec-
tion or  localized  inflammation; however,  M8  had  experi-
enced a  12-hour labor with no progression of cervical di-
latation  and  meconium-stained  liquor  and  had  therefore 
undergone a nonelective Caesarean section. CRP in milk was 
undetected,  and  urinary  lactose  excretion  (4.7  mmol/24 
hours) was just outside the normal range for  OilY  14 (3.4  + 
l.l mmol/24 hours), perhaps indicating a slight increilse in 
breast pcrmeilbility.15 
MS experienced recurrent blocked duct(s) at Days 35, 36, 
65,68,72, 114, and 133  postpartum. Episodes were experi-
enced in differing locations of both the right (II  =  4) and left 
(/I  =  3)  breasts (Fig. 1).  Management consisted of frequent 
feeding, offering the affected breast first, and milssage of the 
ilffected  areil,  resulting  in  resolution of symptoms  by  24 
hours. The only obvious changes that occurred in her milk 
composition were  during episodes experienced  at  Day  36 
and Day 133. During the Day 36 episode both the concen-
tration of Na (12 mmol/L) and Cl (25 mmol/L) in milk from 
the affeded breast were raised, although they did not exceed 
the normal range from asymptomiltic breasts in the study.14 
Milk  lactose  from  the  affected  breast  (176  mmol/L)  was 
within normal  range; however, the excretion of lactose in 
urine was increased (S mmol/24 hours). During the Day 133 
episode, the concentrations of Na (11  mmol/L) and C!  (23 
mmol/L) were again raised compared to her reference mean 
(S.l and 19.6 mmol/L, respectively), this time in association 
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and glucose (0.94  mmol/L). A 24-hour urine specimen was 
not collected. There were no significant changes in milk com-
position observed in  the remaining five episodes. The  lack 
of change was congruent with  the results  from  the other 
women with blocked duct(s) whose milk composition and 
lactose excretion were within  normal  range for the study 
sample.1~ 
Discussion 
Blocked duct(s) are a commonly reported problem among 
breastfeeding women, and although each episode is gener-
ally transient some women can be plagued with many re-
currences throughout their lactation. Reassuringly, unlike in 
mastitis, changes in breastmilk composition arc often either 
absent or short-lived  and of little significance,14 as WilS  the 
case with MS.  During five of the seven episodes of blocked 
duct(s) her milk composition was within the normal range 
for the study sample and did not vary greatly from her own 
asymptomatic reference samples. The variability in milk lac-
tose and  the  excretion of lactose  in  urine during  the  re-
maining two episodes can perhaps be explained  in terms of 
the differing  physiological  stages experienced  from  onset 
through to recovery of the blocked duct(s) and the timing of 
the  milk and 24-hour urine sample collections. As episodes 
of blocked ducts arc generally of short duration, timing of a 
single milk sample collt.'Ction may be crucial to the changes 
observed, especially  in  relation  to the more encompassing 
24-hour urine sample. Changes in  milk composition indica-
tive of an increase in paracellular pathway permeability may 
not be observed as milk from the blocked area may not be 
able to be expressed. The resulting sample, as on the Day 36 
episode, would reflect milk expressed from nonaffected ar-
eas of the breast and thus appear within the normal range. 
However, the concurrent  increased excretion  of lactose in 
urine indicates there was an increase in breast permeability 
•  left breast 
right breast 
_  normal mean 
Patterned columns 
indicate breast with 
blocked segment 
14  30  35  36  60  65  68  72  90  114  133 
Day Postpartum 
FIG. 1.  Concentration of lactoferrin in breastmilk from MS according to day postpartum (columns) compared to the nor-
mal mean lactoferrin of the other study mothers with asymptomatic breasts (solid line). Patterned columns (Days 35, 36, 
65,68,72,114,  ilnd 133) indicate a symptomatic breast with blocked duct(s). Non-patterned columns indicate an asympto-
matic breast. 264 
nol detectable in the milk expressed for analysis, which most 
likely only occurred al the affe<:ted site. In conlrasllo the ma-
jority of thc episodes of blocked duct(s) thc low lactose and 
glucose concentrations on  Day 133 reflect both an increase 
in breast permeability and a dl><:rease in lactose synthcsis.14.1S 
The transient nature of some episodes of breast inflamma-
tion and  the  lack of certainty in being able to express milk 
from  an  area  of  inflammation,  where  the  duct  may  be 
blocked, provide possible explanations for other unusual ob-
servations such as those in one study where a normal Na/K 
ratio was found even in the presence of observable breast in-
flammation and a raised tumor necrosis factor-alpha level in 
milk.I9 
It remains uncertain as to whether the absence of slgA in 
the milk of M8 was a  major contributing  faelor for her ex-
periencing rl-'<:urrent blocked duct(s). As slgA is an ,mti-ad-
ht.'Slve mo!e<:ule, a deficiency of this Ig  may have increased 
the likelihood of bacterial adhesion within the breast, caus-
ing local  inflammation that  was overcome with  more fre-
quent feeding and the subsequent increased flushing of milk. 
The recurrent nature of the problem is suggestive of a sus-
ceptibility of the breast to inflammation that may be related 
to  the absence of IgA and  is supported by another study 
where women who developed mastitis had lower levels of 
slgA in their milk than the normal population.s 
The only other mother in the study with a diagnosed med-
ical condition (M21) was taking thyroxine replacement ther-
apy  for  Hashimoto's  thyroiditis,  an  autoimmune  disease 
charaelerized by destruction of thyroid cells by various cell 
and  antibody-mediated  immune  processes.20  This mother 
experienced  one  episode  of  blocked  duct(s)  and  four 
episodes of mastitis during this lactation and also reported 
a history of multiple recurrent episodes of mastitis with each 
of her previous three lactations. Although thyroiditis is one 
of a number of specific disorders associated with IgA defi-
ciency, this was not the case with M21.  However, she was 
observed to have significantly lower concentrations of slgA 
in her breast  milk during the 9O-day reference collection pe-
riod, lending support to an association among low slgA in 
breastmilk, increased stress, and susceptibility to breast in-
f1ammation.S,8.9.21 The remaining episodes of blocked ducl(s) 
detected  during  the  study  were  associated  with  nipple 
trauma and oversupply, both conditions having been previ-
ously identified as predisposing factors for mastitis.17.22 
The increased concentrations of lactoferrin in the milk of 
M8, particularly in the first 2 weeks postpartum, are of in-
terest. There is  evidence that slgA aels synergistical!y both 
to enhance the bacteriostatic effect of laeloferrin by increas-
ing lactoferrin's sequestration of iron from microorganisms 
and by binding to  lactoferrin, enabling the protein to target 
microorganisms.3 The increase in  lacloferrin in the absence 
of slgA may be suggestive of a compensatory effect.  Vari-
able patterns of compensatory incre<lses of IgG and IgM an-
tibodies have been reported in the milk from three women 
with IgA deficiency.23 Although such analyses were not ob-
tained for the milk from M8, her serum IgG and IgM  WeTI' 
found to be at the higher end of the normal range. The as-
5()ciated high concentration of CRr in blood appears not to 
have been related to the breast as there was no obvious breast 
inflammation, although there was  a  very slight increase in 
urinary  laelose excretion.  This  may  be  related  to  the  in-
creased CRr as  increased breast permeability during lacta-
FETHERSTON  ET  AL. 
tion has been associated with acute systemic  illness in  the 
absence of obvious breast inflammation.24 
Conclusions 
As IgA deficiency has a high incidence in Caucasian pop-
ulations it  may be of value to consider investigating further 
those mothers with either recurrent blocked ducts or masti-
tis who also report a  history suggestive of 19A deficiency, 
such as recurrent ink'<:tions, drug allergy, or autoimmune or 
atopic disease. 
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